Andre C. De Luca - Infectious Diseases

Author Information

Andrea De Luca is a distinguished researcher in the field of Infectious Diseases, particularly focused on HIV and viral hepatitis. He is affiliated with the Unit of Infectious Diseases at the Department of Medical, Surgical and Experimental Sciences, University of Sassari, located in Sassari, Italy. His work is significant in understanding viral infections and their treatments, contributing to advancements in medical science and patient care.

Research Contributions

Andrea De Luca has made substantial contributions to the field of virology and infectious diseases. His research has explored various aspects of HIV management, including the efficacy and durability of antiretroviral therapies, drug resistance, and potential latency-reversing agents. He has also investigated hepatitis C virus monitoring and chronic hepatitis B virus infection. His work extends to epidemiological studies and clinical data analysis, impacting public health strategies and treatment protocols.

Aliases

Andrea De Luca is also known in the academic and research community by several aliases including A De Luca, A. De Luca, and Andre C. De Luca. These variations may appear in different publications and databases.

Publication and Citation Metrics

Metric	Value
Total Citation Count	9983
H-Index	53
Total Paper Count	301

Publications:

Torque Teno Virus plasma level as novel biomarker of retained immunocompetence in HIV-infected patients

DOI: 10.1007/s15010-020-01573-7

Year: 2021

Durability of rilpivirine- versus integrase inhibitor-based regimens in a large cohort of naïve HIV-infected patients starting antiretroviral therapy.

DOI: 10.1016/j.ijantimicag.2021.106406

Year: 2021

Hepatitis C Virus Core Antigen (HCVAg): an affordable assay to monitor the efficacy of treatment in DAAs era.

DOI:

Year: 2021

Maraviroc as a potential HIV-1 latency-reversing agent in cell line models and ex vivo CD4 T cells.

DOI: 10.1099/jgv.0.001499

Year: 2020

First record of Leiostracus demerarensis (L. Pfeiffer, 1861) from Brazil (Gastropoda, Orthalicoidea), with a taxonomic reassessment

DOI: 10.15560/16.2.507

Year: 2020

Analysis of genetic and viral determinants of HBsAg levels in patients with chronic HBV infection.

DOI:

Year: 2020

Transmitted drug resistance to NRTIs and risk of virological failure in naïve patients treated with integrase inhibitors

DOI: 10.1111/hiv.12956

Year: 2020

Epidemiological, demographic and clinical data on chronic viral hepatitis C in Tuscany

DOI: 10.1080/03007995.2018.1482264

Year: 2019

Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort.

DOI: 10.1093/jac/dkz353

Year: 2019

A Comparison between two Dolutegravir-Based two-drug Regimens as Switch Strategies in a Multicentre Cohort of HIV-1-Infected Patients

DOI: 10.3851/IMP3270

Year: 2019

Why Are Asymptomatic Infections Concerning?

How Does Genetic Immunity Work?

What are the advantages of RT-PCR?

What Role Do Metabolic Pathways Play in Antibiotic Resistance?

What is the Treatment for E. Coli Infection?

What Challenges Do Surveillance Systems Face?

What are the Symptoms of Viral Infections?

What is Resource Allocation in Infectious Diseases?

Can Colonization Provide Benefits?

What Role Does Testing Play in Monogamous Relationships?

Partnered Content Networks

Relevant Topics